Author: Healio ophthalmology

Nanotechnology firm to form ophthalmology company

Liquidia Technologies, a nanotechnology-based health care company, will form a new ophthalmology business to move into a high-growth therapeutic area, according to a company news release. The company’s likely lead product is a glaucoma treatment that is expected to enter clinical trials in 2014, the release said.The company uses a proprietary technology platform, called Print, to allow for rapid development and production of precisely engineered particles of almost any size, shape and composition. Liquidia will release additional details on the ophthalmic company later in the second quarter, according to the release.

OSN debuts ‘News You Can Use’ column

I am pleased to pen the inaugural column of “News You Can Use from UPMC Eye Center” for Ocular Surgery News. This column will present clinically relevant information, insights and techniques that we as clinicians can apply to our daily practice of ophthalmology. We at the UPMC Eye Center will do our best to present the most up-to-date material, keeping the focus on the clinical and the here and now. We will also report on the soon-to-come or the just around the corner research and breakthroughs that we see having a significant impact on our clinical practice and patients.